Combination therapy involving antibodies against claudin 18.2 for treatment of pancreatic adenocarcinoma

摘要

The present invention provides a combination therapy for effectively treating and/or preventing diseases associated with cells expressing CLDN18.2, including cancer diseases such as pancreatic cancer and metastases thereof.